HSV-2 Vaccine
All past efforts to develop an HSV-2 vaccine have failed. Our paradigm-shifting vaccine candidate, delta-gD2, promotes a powerful type of immune response overlooked in prior vaccine development efforts.
HIV/HSV-2 syndemic
HSV-2 seropositivity increases the risk of acquiring HIV, and the severity of HIV disease. Click below to learn more about how we are working to identify the mechanisms behind this relationship.
Novel antivirals
HSV has evolved a number of sophisticated mechanisms to establish infection by hijacking the host’s cellular machinery. We are working to characterize these mechanisms and identify novel antivirals.